Furthermore, the expression of GATA3 has been shown to correlate with specific breast cancer phenotypes, defined as luminal type A, carrying an improved disease-free survival and overall survival when compared with tumors that do not express GATA3 [11]. This evidence concerns the gene GATA3 and breast cancer.